GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CG Oncology Inc (NAS:CGON) » Definitions » Other Current Receivables

CG Oncology (CG Oncology) Other Current Receivables : $0.15 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is CG Oncology Other Current Receivables?

CG Oncology's Other Current Receivables for the quarter that ended in Mar. 2024 was $0.15 Mil.

CG Oncology's quarterly Other Current Receivables increased from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($0.09 Mil) and increased from Dec. 2023 ($0.09 Mil) to Mar. 2024 ($0.15 Mil).

CG Oncology's annual Other Current Receivables increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.30 Mil) but then declined from Dec. 2022 ($0.30 Mil) to Dec. 2023 ($0.09 Mil).

CG Oncology Other Current Receivables Historical Data

The historical data trend for CG Oncology's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CG Oncology Other Current Receivables Chart

CG Oncology Annual Data
Trend Dec21 Dec22 Dec23
Other Current Receivables
- 0.30 0.09

CG Oncology Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Other Current Receivables Get a 7-Day Free Trial 0.30 - - 0.09 0.15

CG Oncology Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

CG Oncology Other Current Receivables Related Terms

Thank you for viewing the detailed overview of CG Oncology's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

CG Oncology (CG Oncology) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CG Oncology Inc (NAS:CGON) » Definitions » Other Current Receivables
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Their product candidate cretostimogene, is initially in clinical development for the treatment of patients with high-risk Non-Muscle Invasive Bladder Cancer who are unresponsive to Bacillus Calmette Guerin (BCG) therapy, the current standard-of-care for high-risk NMIBC.

CG Oncology (CG Oncology) Headlines

From GuruFocus

CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024

By Marketwired • 04-24-2024